Elutia (ELUT) Current Deferred Revenue (2019 - 2021)

Elutia (ELUT) reported Current Deferred Revenue of $5000.0 for Q4 2021, down 99.06% on a YoY basis from $533000.0 in Q4 2020, and down 95.45% sequentially from $110000.0 in Q3 2021.

Elutia (ELUT) Current Deferred Revenue (2019 - 2021) Analysis & Trends

Elutia (ELUT) has 3 years of Current Deferred Revenue data on file, last reported at $5000.0 in Q4 2021.

  • For the quarter ending Q4 2021, Current Deferred Revenue fell 99.06% year-over-year to $5000.0; the trailing twelve-month figure through Dec 2021 stood at $5000.0 (down 99.06% YoY), and the FY2021 full-year result was $5000.0, down 99.06% from the prior year.
  • Current Deferred Revenue eased to $5000.0 in Q4 2021, from $110000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $650000.0 in Q4 2019 to a low of $5000.0 in Q4 2021.
  • A 3-year average of $354000.0 and a median of $392000.0 in 2021 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue fell 18.0% in 2020 and plunged 99.06% in 2021, its largest moves.
  • Tracing ELUT's Current Deferred Revenue over 3 years: stood at $650000.0 in 2019, then retreated by 18.0% to $533000.0 in 2020, then sank by 99.06% to $5000.0 in 2021.
  • Business Quant data shows ELUT's Current Deferred Revenue at $5000.0 in Q4 2021, $110000.0 in Q3 2021, and $251000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 5,000.00
Sep 30, 2021 110,000.00
Jun 30, 2021 251,000.00
Mar 31, 2021 392,000.00
Dec 31, 2020 533,000.00
Sep 30, 2020 537,000.00
Dec 31, 2019 650,000.00